Sebastião, Cruz S.
Pingarilho, Marta
Bathy, Jamila
Bonfim, Elizângela
Toancha, Katia
Miranda, Mafalda N.S.
Martins, M Rosário O.
Gomes, Perpetua
Lázaro, Lazismino
Pina-Araujo, Isabel
Nhampossa, Tacilta
Leal, Silvania
Abecasis, Ana B.
Pimentel, Victor
Funding for this research was provided by:
Foundation for Science and Technology (FCT) funded the MARVEL project (PTDC/SAU-PUB/4018/2021, PTDC/SAU-PUB/4018/2021, PTDC/SAU-PUB/4018/2021, PTDC/SAU-PUB/4018/2021, PTDC/SAU-PUB/4018/2021)
Calouste Gulbenkian Foundation (FCG), HITOLA project (250466)
GHTM (GHTM-UID/04413/2020, GHTM-UID/04413/2020, GHTM-UID/04413/2020, GHTM-UID/04413/2020, GHTM-UID/04413/2020)
LA-REAL (LA/P/0117/2020, LA/P/0117/2020, LA/P/0117/2020, LA/P/0117/2020, LA/P/0117/2020)
Article History
Received: 12 August 2024
Accepted: 22 August 2024
First Online: 29 August 2024
Declarations
:
: The research team will ensure data protection according to the Helsinki Declaration. The study protocol was submitted to ethical committees of participating healthcare institutions in Angola, Cape Verde, Mozambique, and Sao Tome & Principe. The study participants will receive written information, including the description and the goals of the study, as well as, information about data privacy procedures. Moreover, informed signed consent will be requested from all participants before they are enrolled in the study. All samples stored will be analysed and destroyed no later than December 31, 2044, following current legal and ethical requirements.
: Not applicable.
: The authors declare no competing interests.